Walk down the quit-aid aisle and it looks like a lot of choice. It's mostly the same choice, worn differently. Patches, gum, lozenges and sprays are all nicotine replacement therapy — different delivery speeds, same active ingredient. Choosing between them is really choosing how you want your nicotine, not whether you're still having it.
Patches deliver a steady background dose over the day — no action required, but also nothing to reach for in the actual moment of a craving.
Gum and lozenges are faster-acting and give you something to do with your hands and mouth in the moment — which matters more than it sounds, since a lot of the vaping habit is physical, not just chemical.
Sprays are the fastest of the bunch, built for sudden, sharp cravings.
All four are genuinely effective tools for people managing nicotine dependence. One trial comparing e-cigarettes with NRT for smoking cessation found
"E-cigarette users were more likely to achieve reduced cigarette consumption."
— PMC, RCT
than those using OTC NRT alone — a reminder that even within nicotine-based options, format changes the outcome. CURBi isn't here to talk anyone out of using any of them — it can be used alongside NRT, not just instead of it. What none of them do is give you an option that's nicotine-free from the start.
That's where CURBi sits apart from the list above, rather than alongside it. It's a chewable tablet — same instinct as reaching for a lozenge or gum in the moment a craving hits — built with non-addictive actives instead of nicotine. Chew one every 2–3 hours, up to 8 a day, and it's designed for the same trigger moments patches, gum, lozenges and sprays are built for. The difference is what's actually in it: nothing there to get hooked on in the first place.
Sources
Vaping cessation: how to treat nicotine dependence — PMC
Is dual use of nicotine products and cigarettes associated with cessation? — PMC